PTThe Paper Trail Project
Sourced institutional rolesLDA lobbying records

DARREN WILLCOX

DARREN WILLCOX appears as a registered lobbyist in federal Lobbying Disclosure Act records connected to organizations tracked by Paper Trail.

Data updated Aug 31, 2026

Source-backed chronology

Career Timeline

Dates not reported

Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff Director

Federal government

Inspect source ↗

Documented career transitions

Revolving Door

Congress → Lobbying

Federal governmentAsst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff DirectorMcKessonRegistered lobbyist

Federal LDA filings

Lobbying Activity

MCKESSON CORPORATION4th Quarter (Oct 1 - Dec 31) 2017

Registrant: W STRATEGIES, LLC · Health Issues

Implementation of Comprehensive Addiction and Recovery Act (CARA) PL 114-198 and education regarding opioid treatment and prevention.

LDA filing ↗
MCKESSON CORPORATION3rd Quarter (July 1 - Sep 30) 2024

Registrant: W STRATEGIES, LLC · Medicare/Medicaid

H.R.1770 - Equitable Community Access to Pharmacist Services Act.

LDA filing ↗
MCKESSON CORPORATION1st Quarter (Jan 1 - Mar 31) 2024

Registrant: W STRATEGIES, LLC · Pharmacy

Issues related to the drug supply chain, transparency and patient access to medicines.

LDA filing ↗
MCKESSON CORPORATION3rd Quarter (July 1 - Sep 30) 2024

Registrant: W STRATEGIES, LLC · Pharmacy

Issues related to the drug supply chain, transparency and patient access to medicines.

LDA filing ↗
MCKESSON CORPORATION4th Quarter (Oct 1 - Dec 31) 2018

Registrant: W STRATEGIES, LLC · Health Issues

Education about improvements to Prescription Drug Monitoring programs that would promote greater efficiency and utility at the pharmacy and other issues related to opioid abuse.

LDA filing ↗
MCKESSON CORPORATION2nd Quarter (Apr 1 - June 30) 2018

Registrant: W STRATEGIES, LLC · Health Issues

Education about improvements to Prescription Drug Monitoring programs that would promote greater efficiency and utility at the pharmacy. H.R.6: Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act.

LDA filing ↗
MCKESSON CORPORATION2nd Quarter (Apr 1 - June 30) 2024

Registrant: W STRATEGIES, LLC · Pharmacy

Issues related to the drug supply chain, transparency and patient access to medicines.

LDA filing ↗
MCKESSON CORPORATION3rd Quarter (July 1 - Sep 30) 2017

Registrant: W STRATEGIES, LLC · Health Issues

Incentives for health information technology including the adoption of electronic health records. Implementation of Comprehensive Addiction and Recovery Act (CARA) PL 114-198 and education regarding opioid treatment and prevention.

LDA filing ↗
MCKESSON CORPORATION1st Quarter (Jan 1 - Mar 31) 2019

Registrant: W STRATEGIES, LLC · Medicare/Medicaid

Regulatory and legislative proposals in the Administrations Blueprint.

LDA filing ↗
MCKESSON CORPORATION1st Quarter (Jan 1 - Mar 31) 2019

Registrant: W STRATEGIES, LLC · Health Issues

Education about improvements to Prescription Drug Monitoring programs that would promote greater efficiency and utility at the pharmacy and other issues related to opioid abuse.

LDA filing ↗
MCKESSON CORPORATION4th Quarter (Oct 1 - Dec 31) 2024

Registrant: W STRATEGIES, LLC · Pharmacy

Issues related to the drug supply chain, transparency and patient access to medicines.

LDA filing ↗
MCKESSON CORPORATION4th Quarter (Oct 1 - Dec 31) 2024

Registrant: W STRATEGIES, LLC · Medicare/Medicaid

H.R.1770 - Equitable Community Access to Pharmacist Services Act.

LDA filing ↗
MCKESSON CORPORATION3rd Quarter (July 1 - Sep 30) 2018

Registrant: W STRATEGIES, LLC · Health Issues

Education about improvements to Prescription Drug Monitoring programs that would promote greater efficiency and utility at the pharmacy. H.R.6: Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act.

LDA filing ↗
MCKESSON CORPORATION1st Quarter (Jan 1 - Mar 31) 2018

Registrant: W STRATEGIES, LLC · Health Issues

Implementation of Comprehensive Addiction and Recovery Act (CARA) PL 114-198 and education regarding opioid treatment, distribution and prevention.

LDA filing ↗
MCKESSON CORPORATION2nd Quarter (Apr 1 - June 30) 2016

Registrant: W STRATEGIES, LLC · Health Issues

Legislative initiatives related to prescription drug abuse and diversion. S. 524: Comprehensive Addiction and Recovery Act of 2016.

LDA filing ↗
MCKESSON CORPORATION2nd Quarter (Apr 1 - June 30) 2017

Registrant: W STRATEGIES, LLC · Health Issues

Incentives for health information technology including the adoption of electronic health records. Implementation of Comprehensive Addiction and Recovery Act (CARA) PL 114-198 and education regarding opioid treatment and prevention.

LDA filing ↗
MCKESSON CORPORATION2nd Quarter (Apr 1 - June 30) 2017

Registrant: W STRATEGIES, LLC · Veterans

Education around Electronic Health Records and Rx distribution at the VA.

LDA filing ↗
MCKESSON CORPORATION2nd Quarter (Apr 1 - June 30) 2016

Registrant: W STRATEGIES, LLC · Medicare/Medicaid

March 2016 CMS proposed rule implementing a new Part B drug payment model.

LDA filing ↗
MCKESSON CORPORATION1st Quarter (Jan 1 - Mar 31) 2017

Registrant: W STRATEGIES, LLC · Health Issues

Incentives for health information technology including the adoption of electronic health records. Implementation of Comprehensive Addiction and Recovery Act (CARA) PL 114-198 and education regarding opioid treatment and prevention.

LDA filing ↗